Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +1.43% | -0.70% | -38.42% |
Business Summary
Number of employees: 23
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Treatments for Solid Tumor Cancers
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.35% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
William Gray
DFI | Director of Finance/CFO | 36 | 16-01-31 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Director/Board Member | 68 | 14-11-09 | |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 14-11-09 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Christian Béchon
BRD | Director/Board Member | 63 | 18-10-15 |
Barry Salzman
BRD | Director/Board Member | 62 | 15-12-31 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 700,000 | 0 | 0 | 90.32 % |
Stock B | 1 | 34,986,279 | 32,232,682 ( 92.13 %) | 0 |
Company contact information
Checkpoint Therapeutics, Inc.
95 Sawyer Road Suite 110
02453, Waltham
+781 652 4500
http://www.checkpointtx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.42% | 49.96M | |
+18.50% | 42.68B | |
-1.47% | 42.4B | |
+46.51% | 40.04B | |
-6.20% | 28.31B | |
+6.76% | 24.94B | |
-23.01% | 18.96B | |
+29.90% | 12.3B | |
-1.95% | 11.95B | |
-3.95% | 11.55B |
- Stock Market
- Equities
- CKPT Stock
- Company Checkpoint Therapeutics, Inc.